Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 958243, 9 pages
http://dx.doi.org/10.1155/2011/958243
Research Article

Growth Inhibition and Induction of Apoptosis in SHG-44 Glioma Cells by Chinese Medicine Formula “Pingliu Keli”

Laboratory of Cellular and Molecular Biology, Jiangsu Province Institute of Traditional Chinese Medicine, no. 100, Shizi Street, Hongshang Road, Nanjing, Jiangsu 210028, China

Received 18 January 2010; Revised 1 April 2010; Accepted 30 June 2010

Copyright © 2011 Peng Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Deltour, C. Johansen, A. Auvinen, M. Feychting, L. Klaeboe, and J. Schüz, “Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974–2003,” Journal of the National Cancer Institute, vol. 101, no. 24, pp. 1721–1724, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. T. Ullrich, L. W. Kracht, and A. H. Jacobs, “Neuroimaging in patients with gliomas,” Seminars in Neurology, vol. 28, no. 4, pp. 484–494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Kefas, L. Comeau, D. H. Floyd et al., “The neuronal microRNA miR-326 acts in a feedback loop with Notch and has therapeutic potential against brain tumors,” Journal of Neuroscience, vol. 29, no. 48, pp. 15161–15168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. C. Miller, “Echinacea: a miracle herb against aging and cancer? Evidence in vivo in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 309–314, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Kiyohara, T. Matsumoto, and H. Yamada, “Combination effects of herbs in a multi-herbal formula: expression of Juzen-taiho-to's immuno-modulatory activity on the intestinal immune system,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 83–91, 2004. View at Google Scholar
  6. A. Kondo, S. Goldman, R. R. Lulla et al., “Longitudinal assessment of regional directed delivery in a rodent malignant glioma model,” Journal of Neurosurgery, vol. 4, no. 6, pp. 592–598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. L. Palmer, “Neurodevelopmental impact on children treated for medulloblastoma: a review and proposed conceptual model,” Developmental Disabilities Research Reviews, vol. 14, no. 3, pp. 203–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Meng, Y. Niu, X. Niu, R. H. Roubin, and J. R. Hanrahan, “Ethnobotany, phytochemistry and pharmacology of the genus Caragana used in traditional Chinese medicine,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 350–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Azaizeh, B. Saad, K. Khalil, and O. Said, “The state of the art of traditional Arab herbal medicine in the Eastern region of the Mediterranean: a review,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 2, pp. 229–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-X. Zhao, F.-L. Guo, D.-C. Bai, and X.-X. Wang, “Effects of Fuzheng Yiliu Granules on apoptotic rate and mitochondrial membrane potential of hepatocellular carcinoma cell line H22 from mice,” Journal of Chinese Integrative Medicine, vol. 4, no. 3, pp. 271–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Eramo, R. Pallini, F. Lotti et al., “Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction,” Cancer Research, vol. 65, no. 24, pp. 11469–11477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Mukherjee, A. Ghosh, A. Ghosh, and S. Chaudhuri, “ENU administration causes genomic instability along with single nucleotide polymorphisms in p53 during gliomagenesis: T11TS administration demonstrated in vivo apoptosis of these genetically altered tumor cells,” Cancer Biology and Therapy, vol. 5, no. 2, pp. 156–164, 2006. View at Google Scholar · View at Scopus
  13. M. J. Son, J. S. Kim, M. H. Kim et al., “Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model,” International Journal of Oncology, vol. 28, no. 1, pp. 53–59, 2006. View at Google Scholar · View at Scopus
  14. L. S. Einbond, Y. Wen-Cai, K. He et al., “Growth inhibitory activity of extracts and compounds from Cimicifuga species on human breast cancer cells,” Phytomedicine, vol. 15, no. 6-7, pp. 504–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Chabi, V. Ljubicic, K. J. Menzies, J. H. Huang, A. Saleem, and D. A. Hood, “Mitochondrial function and apoptotic susceptibility in aging skeletal muscle,” Aging Cell, vol. 7, no. 1, pp. 2–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Zhou, “New phosphatidylserine receptors: clearance of apoptotic cells and more,” Developmental Cell, vol. 13, no. 6, pp. 759–760, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Chen, Y.-H. Su, C.-H. Wang, J.-M. Wu, J.-C. Chen, and S.-H. Tseng, “Induction of apoptosis and cell cycle arrest in glioma cells by GL331 (a topoisomerase II inhibitor),” Anticancer Research, vol. 25, no. 6, pp. 4203–4208, 2005. View at Google Scholar · View at Scopus
  18. A. Panner, C. D. James, M. S. Berger, and R. O. Pieper, “mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells,” Molecular and Cellular Biology, vol. 25, no. 20, pp. 8809–8823, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Khalid, Y. Tokunaga, A. J. Caputy, and E. Walters, “Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole,” Journal of Neurosurgery, vol. 103, no. 1, pp. 79–86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. Graff, A. M. McNulty, K. R. Hanna et al., “The protein kinase Cβ-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts,” Cancer Research, vol. 65, no. 16, pp. 7462–7469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. W.Y. Wu-Chen, D. A. Jacobs, N. J. Volpe, J. O. Dalmau, and M. L. Moster, “Intracranial malignancies occurring more than 20 years after radiation therapy for pituitary adenoma,” Journal of Neuro-Ophthalmology, vol. 29, no. 4, pp. 289–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. N. G. Thaker and I. F. Pollack, “Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies,” Expert Review of Neurotherapeutics, vol. 9, no. 12, pp. 1815–1836, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kombos, T. Picht, A. Derdilopoulos, and O. Suess, “Impact of intraoperative neurophysiological monitoring on surgery of high-grade gliomas,” Journal of Clinical Neurophysiology, vol. 26, pp. 422–425, 2009. View at Google Scholar
  24. M. J. McGirt, K. L. Chaichana, M. Gathinji et al., “Independent association of extent of resection with survival in patients with malignant brain astrocytoma,” Journal of Neurosurgery, vol. 110, no. 1, pp. 156–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. J. Cao, B. K. Yang, and J. G. Huo, “Clinical investigation of Pingliu keli on treatment on glioma,” Shandong Journal of Traditional Chinese Medicine, vol. 2, pp. 78–79, 2005. View at Google Scholar
  26. J. G. Huo, “The progress of integrated Chinese and Western medicine treatment on Glioma,” Jiangsu Journal of Traditional Chinese Medicine, vol. 2, pp. 26–28, 2006. View at Google Scholar